Fulcrum Therapeutics, Inc. (FULC): Price and Financial Metrics

Fulcrum Therapeutics, Inc. (FULC): $3.48

0.21 (+6.42%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

B

Add FULC to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#21 of 329

in industry

FULC Price/Volume Stats

Current price $3.48 52-week high $13.70
Prev. close $3.27 52-week low $2.87
Day low $3.26 Volume 651,400
Day high $3.50 Avg. volume 1,024,983
50-day MA $6.53 Dividend yield N/A
200-day MA $7.75 Market Cap 216.30M

FULC Stock Price Chart Interactive Chart >


Fulcrum Therapeutics, Inc. (FULC) Company Bio


Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015 and is headquartered in Cambridge, MA.


FULC Latest News Stream


Event/Time News Detail
Loading, please wait...

FULC Latest Social Stream


Loading social stream, please wait...

View Full FULC Social Stream

FULC Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!